Central nervous system(CNS) diseases have become a major global public health challenge. Intranasal administration offers a promising, non-invasive delivery route for drugs to the brain by bypassing the blood-brain barrier, avoiding the first-pass effect, achieving high bioavailability of drugs in the brain, as well as improving patient compliance and convenience. However, conventional intranasal delivery is limited by rapid mucociliary clearance and poor targeting efficiency. Nano drug delivery systems exhibit unique advantages, such as a high specific surface area, adjustable structure and modifiable surfaces, which could improve drug stability, prolong mucosal retention and enhance targeted delivery to the brain. The integration of nose-to-brain targeting strategies with nanotechnology offers a promising approach for efficient drug delivery to the CNS. This review provides a systematic overview of recent advances in nose-to-brain nano drug delivery systems, focusing on key approaches to enhance delivery efficiency. It aims to offer theoretical guidance for the rational design and clinical translation of such systems.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |